SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
₹1,773.40
arrow_upward
+0.20%(+3.50) 1D
Nov 4, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUNPHARMA...
Open
₹1,769.90
High
₹1,810.40
Low
₹1,769.00
Mkt. cap
4.26T
Avg. vol.
1.74M
Volume
4.93M
Dividend
0.90%
Quarterly dividend
₹4.00
Ex-dividend date
Jul 7, 2026
P/E ratio
38.77
52-wk high
₹2,046.90
52-wk low
₹1,583.70
EPS
₹45.74
Shares outstanding
0.00
No. of employees
47K
Open
₹1,769.90
High
₹1,810.40
Low
₹1,769.00
Mkt. cap
4.26T
Avg. vol.
1.74M
Volume
4.93M
Dividend
0.90%
Quarterly dividend
₹4.00
Ex-dividend date
Jul 7, 2026
P/E ratio
38.77
52-wk high
₹2,046.90
52-wk low
₹1,583.70
EPS
₹45.74
Shares outstanding
0.00
No. of employees
47K
News stories
From web sources and news partners
Yahoo Finance Singapore
·
1 day ago
Sun Pharmaceuticals Industries Ltd (BOM:524715) (Q2 2027) Earnings Call Highlights: India ...
TradingView
·
2 days ago
Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Moneycontrol.com
·
2 days ago
Sun Pharma shares fall 3% after Q2 profit plunges 36%; brokerages bullish but slash target prices
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47K
Founded1983
HeadquartersGoregaon East, Mumbai, India
SectorPharmaceutical industry
Industry-
Websitesunpharma.com